AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. HI
  4. [Form 4] Hillenbrand, Inc. Insider Trading Activity

[Form 4] Hillenbrand, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Leidos Holdings, Inc. (LDOS) 鈥� Form 4 insider transaction

Chief Financial Officer Christopher R. Cage reported one transaction dated 06/30/2025.

  • Acquisition: 64.1944 shares of common stock credited at $0.00 per share. The shares represent dividend-equivalent rights that were automatically reinvested in the company鈥檚 Key Executive Stock Deferral Plan.
  • Post-transaction ownership: 29,288.682 indirect shares held via the deferral plan and 46,953 direct shares.

No derivative securities were involved and no sales were disclosed. The filing does not indicate any open-market purchases or dispositions; the recorded activity is routine and non-cash. Given the immaterial share amount relative to the executive鈥檚 existing holdings, the filing is unlikely to have a meaningful impact on LDOS鈥檚 share count or market perception.

Leidos Holdings, Inc. (LDOS) 鈥� Transazione insider Form 4

Il Chief Financial Officer Christopher R. Cage ha riportato una transazione datata 30/06/2025.

  • Acquisizione: 64,1944 azioni ordinarie accreditate a $0,00 per azione. Le azioni rappresentano diritti equivalenti ai dividendi reinvestiti automaticamente nel Piano di Differimento Azionario per Dirigenti Chiave della societ脿.
  • Propriet脿 post-transazione: 29.288,682 azioni indirette detenute tramite il piano di differimento e 46.953 azioni dirette.

Non sono stati coinvolti titoli derivati n茅 sono state effettuate vendite. Il deposito non indica acquisti o cessioni sul mercato aperto; l'attivit脿 registrata 猫 di routine e non comporta movimenti in contanti. Considerando la quantit脿 di azioni irrilevante rispetto alle partecipazioni esistenti del dirigente, 猫 improbabile che il deposito abbia un impatto significativo sul numero di azioni di LDOS o sulla percezione del mercato.

Leidos Holdings, Inc. (LDOS) 鈥� Transacci贸n interna Formulario 4

El Director Financiero Christopher R. Cage report贸 una transacci贸n fechada el 30/06/2025.

  • 础诲辩耻颈蝉颈肠颈贸苍: 64,1944 acciones ordinarias acreditadas a $0.00 por acci贸n. Las acciones representan derechos equivalentes a dividendos que se reinvirtieron autom谩ticamente en el Plan de Diferimiento de Acciones para Ejecutivos Clave de la empresa.
  • Propiedad tras la transacci贸n: 29.288,682 acciones indirectas mantenidas a trav茅s del plan de diferimiento y 46.953 acciones directas.

No se involucraron valores derivados ni se divulgaron ventas. La presentaci贸n no indica compras o disposiciones en el mercado abierto; la actividad registrada es rutinaria y sin efectivo. Dado el monto insignificante de acciones en relaci贸n con las participaciones existentes del ejecutivo, es poco probable que la presentaci贸n tenga un impacto significativo en el recuento de acciones de LDOS o en la percepci贸n del mercado.

Leidos Holdings, Inc. (LDOS) 鈥� Form 4 雮措秬鞛� 瓯半灅

斓滉碃鞛毂呾瀯鞛�(Chief Financial Officer) Christopher R. Cage臧� 2025雲� 6鞗� 30鞚检瀽 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟.

  • 旆摑: 氤错喌欤� 64.1944欤�, 欤茧嫻 $0.00搿� 鞝侂霅�. 鞚� 欤检嫕鞚� 氚半嫻瓿� 霃欖澕頃� 甓岆Μ毳� 雮橅儉雮措┌ 須岇偓鞚� 欤检殧 鞛勳洂 欤检嫕 鞚挫棸 瓿勴殟鞐� 鞛愲彊 鞛埇鞛愲悩鞐堨姷雼堧嫟.
  • 瓯半灅 頉� 靻岇湢: 鞚挫棸 瓿勴殟鞚� 韱淀暣 臧勳爲 氤挫湢頃� 29,288.682欤检檧 歆侅爲 氤挫湢頃� 46,953欤�.

韺岇儩 歃濌秾鞚� 韽暔霅橃 鞎婌晿鞙茧┌ 韺愲Г霃� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�. 鞝滌稖 靹滊鞐愲姅 瓿店皽 鞁滌灔鞐愳劀鞚� 毵れ垬 霕愲姅 毵る弰臧� 氇呾嫓霅橃柎 鞛堨 鞎婌溂氅�, 旮半霅� 頇滊彊鞚� 鞚检儊鞝侅澊瓿� 順勱笀鞚� 靾橂皹霅橃 鞎婌姷雼堧嫟. 鞛勳洂鞚� 旮办〈 氤挫湢 欤检嫕鞐� 牍勴暣 氙鸽頃� 欤检嫕 靾橂焿鞙茧 鞚疙暣 鞚� 鞝滌稖 靹滊臧� LDOS鞚� 欤检嫕 靾橂倶 鞁滌灔 鞚胳嫕鞐� 鞚橂 鞛堧姅 鞓來枼鞚� 氙胳範 臧�電レ劚鞚� 雮姷雼堧嫟.

Leidos Holdings, Inc. (LDOS) 鈥� Transaction d鈥檌niti茅 Formulaire 4

Le directeur financier Christopher R. Cage a d茅clar茅 une transaction dat茅e du 30/06/2025.

  • Acquisition : 64,1944 actions ordinaires cr茅dit茅es 脿 0,00 $ par action. Ces actions repr茅sentent des droits 茅quivalents aux dividendes qui ont 茅t茅 automatiquement r茅investis dans le plan de report d鈥檃ctions des cadres cl茅s de la soci茅t茅.
  • Propri茅t茅 apr猫s transaction : 29 288,682 actions indirectes d茅tenues via le plan de report et 46 953 actions directes.

Aucun titre d茅riv茅 n鈥檃 茅t茅 impliqu茅 et aucune vente n鈥檃 茅t茅 divulgu茅e. Le d茅p么t n鈥檌ndique aucun achat ou disposition sur le march茅 ouvert ; l鈥檃ctivit茅 enregistr茅e est de routine et sans flux de tr茅sorerie. 脡tant donn茅 le nombre insignifiant d鈥檃ctions par rapport aux avoirs existants du dirigeant, il est peu probable que ce d茅p么t ait un impact significatif sur le nombre d鈥檃ctions de LDOS ou sur la perception du march茅.

Leidos Holdings, Inc. (LDOS) 鈥� Form 4 Insider-Transaktion

Chief Financial Officer Christopher R. Cage meldete eine Transaktion vom 30.06.2025.

  • Erwerb: 64,1944 Stammaktien zu $0,00 pro Aktie gutgeschrieben. Die Aktien stellen dividenden盲quivalente Rechte dar, die automatisch im Key Executive Stock Deferral Plan des Unternehmens reinvestiert wurden.
  • Besitz nach der Transaktion: 29.288,682 indirekte Aktien, gehalten 眉ber den Deferral Plan, und 46.953 direkte Aktien.

Es waren keine Derivate beteiligt und keine Verk盲ufe wurden gemeldet. Die Einreichung weist keine K盲ufe oder Ver盲u脽erungen am offenen Markt aus; die aufgezeichnete Aktivit盲t ist routinem盲脽ig und nicht zahlungswirksam. Angesichts der unerheblichen Aktienanzahl im Verh盲ltnis zu den bestehenden Best盲nden des Executive ist es unwahrscheinlich, dass die Einreichung eine bedeutende Auswirkung auf die Aktienanzahl oder die Marktwahrnehmung von LDOS hat.

Positive
  • CFO increased indirect holdings, albeit by only 64 shares, which marginally aligns executive incentives with shareholders.
Negative
  • Transaction size is immaterial (鈮�0.0001% of shares outstanding) and provides no actionable insight into management鈥檚 outlook.

Insights

TL;DR: Routine dividend-equivalent share accrual; negligible market impact.

The CFO鈥檚 acquisition of 64 shares at no cost is a standard bookkeeping entry tied to deferred compensation. After the credit, his indirect holdings total roughly 29.3k shares, while direct ownership remains 46.9k shares. There is no evidence of discretionary buying or selling, and the transaction neither signals bullish nor bearish sentiment. Investors can treat the filing as administratively neutral.

Leidos Holdings, Inc. (LDOS) 鈥� Transazione insider Form 4

Il Chief Financial Officer Christopher R. Cage ha riportato una transazione datata 30/06/2025.

  • Acquisizione: 64,1944 azioni ordinarie accreditate a $0,00 per azione. Le azioni rappresentano diritti equivalenti ai dividendi reinvestiti automaticamente nel Piano di Differimento Azionario per Dirigenti Chiave della societ脿.
  • Propriet脿 post-transazione: 29.288,682 azioni indirette detenute tramite il piano di differimento e 46.953 azioni dirette.

Non sono stati coinvolti titoli derivati n茅 sono state effettuate vendite. Il deposito non indica acquisti o cessioni sul mercato aperto; l'attivit脿 registrata 猫 di routine e non comporta movimenti in contanti. Considerando la quantit脿 di azioni irrilevante rispetto alle partecipazioni esistenti del dirigente, 猫 improbabile che il deposito abbia un impatto significativo sul numero di azioni di LDOS o sulla percezione del mercato.

Leidos Holdings, Inc. (LDOS) 鈥� Transacci贸n interna Formulario 4

El Director Financiero Christopher R. Cage report贸 una transacci贸n fechada el 30/06/2025.

  • 础诲辩耻颈蝉颈肠颈贸苍: 64,1944 acciones ordinarias acreditadas a $0.00 por acci贸n. Las acciones representan derechos equivalentes a dividendos que se reinvirtieron autom谩ticamente en el Plan de Diferimiento de Acciones para Ejecutivos Clave de la empresa.
  • Propiedad tras la transacci贸n: 29.288,682 acciones indirectas mantenidas a trav茅s del plan de diferimiento y 46.953 acciones directas.

No se involucraron valores derivados ni se divulgaron ventas. La presentaci贸n no indica compras o disposiciones en el mercado abierto; la actividad registrada es rutinaria y sin efectivo. Dado el monto insignificante de acciones en relaci贸n con las participaciones existentes del ejecutivo, es poco probable que la presentaci贸n tenga un impacto significativo en el recuento de acciones de LDOS o en la percepci贸n del mercado.

Leidos Holdings, Inc. (LDOS) 鈥� Form 4 雮措秬鞛� 瓯半灅

斓滉碃鞛毂呾瀯鞛�(Chief Financial Officer) Christopher R. Cage臧� 2025雲� 6鞗� 30鞚检瀽 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟.

  • 旆摑: 氤错喌欤� 64.1944欤�, 欤茧嫻 $0.00搿� 鞝侂霅�. 鞚� 欤检嫕鞚� 氚半嫻瓿� 霃欖澕頃� 甓岆Μ毳� 雮橅儉雮措┌ 須岇偓鞚� 欤检殧 鞛勳洂 欤检嫕 鞚挫棸 瓿勴殟鞐� 鞛愲彊 鞛埇鞛愲悩鞐堨姷雼堧嫟.
  • 瓯半灅 頉� 靻岇湢: 鞚挫棸 瓿勴殟鞚� 韱淀暣 臧勳爲 氤挫湢頃� 29,288.682欤检檧 歆侅爲 氤挫湢頃� 46,953欤�.

韺岇儩 歃濌秾鞚� 韽暔霅橃 鞎婌晿鞙茧┌ 韺愲Г霃� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�. 鞝滌稖 靹滊鞐愲姅 瓿店皽 鞁滌灔鞐愳劀鞚� 毵れ垬 霕愲姅 毵る弰臧� 氇呾嫓霅橃柎 鞛堨 鞎婌溂氅�, 旮半霅� 頇滊彊鞚� 鞚检儊鞝侅澊瓿� 順勱笀鞚� 靾橂皹霅橃 鞎婌姷雼堧嫟. 鞛勳洂鞚� 旮办〈 氤挫湢 欤检嫕鞐� 牍勴暣 氙鸽頃� 欤检嫕 靾橂焿鞙茧 鞚疙暣 鞚� 鞝滌稖 靹滊臧� LDOS鞚� 欤检嫕 靾橂倶 鞁滌灔 鞚胳嫕鞐� 鞚橂 鞛堧姅 鞓來枼鞚� 氙胳範 臧�電レ劚鞚� 雮姷雼堧嫟.

Leidos Holdings, Inc. (LDOS) 鈥� Transaction d鈥檌niti茅 Formulaire 4

Le directeur financier Christopher R. Cage a d茅clar茅 une transaction dat茅e du 30/06/2025.

  • Acquisition : 64,1944 actions ordinaires cr茅dit茅es 脿 0,00 $ par action. Ces actions repr茅sentent des droits 茅quivalents aux dividendes qui ont 茅t茅 automatiquement r茅investis dans le plan de report d鈥檃ctions des cadres cl茅s de la soci茅t茅.
  • Propri茅t茅 apr猫s transaction : 29 288,682 actions indirectes d茅tenues via le plan de report et 46 953 actions directes.

Aucun titre d茅riv茅 n鈥檃 茅t茅 impliqu茅 et aucune vente n鈥檃 茅t茅 divulgu茅e. Le d茅p么t n鈥檌ndique aucun achat ou disposition sur le march茅 ouvert ; l鈥檃ctivit茅 enregistr茅e est de routine et sans flux de tr茅sorerie. 脡tant donn茅 le nombre insignifiant d鈥檃ctions par rapport aux avoirs existants du dirigeant, il est peu probable que ce d茅p么t ait un impact significatif sur le nombre d鈥檃ctions de LDOS ou sur la perception du march茅.

Leidos Holdings, Inc. (LDOS) 鈥� Form 4 Insider-Transaktion

Chief Financial Officer Christopher R. Cage meldete eine Transaktion vom 30.06.2025.

  • Erwerb: 64,1944 Stammaktien zu $0,00 pro Aktie gutgeschrieben. Die Aktien stellen dividenden盲quivalente Rechte dar, die automatisch im Key Executive Stock Deferral Plan des Unternehmens reinvestiert wurden.
  • Besitz nach der Transaktion: 29.288,682 indirekte Aktien, gehalten 眉ber den Deferral Plan, und 46.953 direkte Aktien.

Es waren keine Derivate beteiligt und keine Verk盲ufe wurden gemeldet. Die Einreichung weist keine K盲ufe oder Ver盲u脽erungen am offenen Markt aus; die aufgezeichnete Aktivit盲t ist routinem盲脽ig und nicht zahlungswirksam. Angesichts der unerheblichen Aktienanzahl im Verh盲ltnis zu den bestehenden Best盲nden des Executive ist es unwahrscheinlich, dass die Einreichung eine bedeutende Auswirkung auf die Aktienanzahl oder die Marktwahrnehmung von LDOS hat.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Greenway Joy M
(Last) (First) (Middle)
ONE BATESVILLE BOULEVARD
(Street)
BATESVILLE IN 47006
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Hillenbrand, Inc. [ HI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (Deferred Stock Award 2/27/13) (1) 06/30/2025 A(2) 28 (3) (3) Common Stock 28 $0 2,641 D
Restricted Stock Units (Deferred Stock Award 2/26/14) (1) 06/30/2025 A(2) 45 (3) (3) Common Stock 45 $0 4,143 D
Restricted Stock Units (Deferred Stock Award 2/25/15) (1) 06/30/2025 A(2) 45 (3) (3) Common Stock 45 $0 4,093 D
Restricted Stock Units (Deferred Stock Award 2/24/16) (1) 06/30/2025 A(2) 51 (3) (3) Common Stock 51 $0 4,658 D
Restricted Stock Units (Deferred Stock Award 2/22/17) (1) 06/30/2025 A(2) 36 (3) (3) Common Stock 36 $0 3,292 D
Restricted Stock Units (Deferred Stock Award 2/15/18) (1) 06/30/2025 A(2) 32 (3) (3) Common Stock 32 $0 2,909 D
Restricted Stock Units (Deferred Stock Award 2/14/19) (1) 06/30/2025 A(2) 32 (3) (3) Common Stock 32 $0 2,918 D
Restricted Stock Units (Deferred Stock Award 2/13/20) (1) 06/30/2025 A(2) 48 (3) (3) Common Stock 48 $0 4,364 D
Restricted Stock Units (Deferred Stock Award 2/11/21) (1) 06/30/2025 A(2) 34 (4) (4) Common Stock 34 $0 3,074 D
Restricted Stock Units (Deferred Stock Award 2/10/22) (1) 06/30/2025 A(2) 31 (4) (4) Common Stock 31 $0 2,839 D
Restricted Stock Units (Deferred Stock Award 2/24/23) (1) 06/30/2025 A(2) 32 (4) (4) Common Stock 32 $0 2,889 D
Restricted Stock Units (Deferred Stock Award 2/20/24) (1) 06/30/2025 A(2) 34 (4) (4) Common Stock 34 $0 3,139 D
Restricted Stock Units (Deferred Stock Award 2/18/25) (1) 06/30/2025 A(2) 45 (4) (4) Common Stock 45 $0 4,088 D
Explanation of Responses:
1. Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock.
2. Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates.
3. These Restricted Stock Units vest immediately upon grant. However, for awards granted prior to May 2014, directors must hold the underlying shares of common stock of the Company for six months after they cease serving as a director, and for awards granted in May 2014 or later, directors must hold the underlying shares of common stock of the Company for one day after the director ceases serving.
4. These Restricted Stock Units vest on the earlier to occur of the issuer's next annual meeting of shareholders or one year from the date of grant; provided, that these Restricted Stock Units will immediately vest upon, and in any case delivery of the shares underlying these Restricted Stock Units will not occur until, the occurrence of one of the following: a change in control of the issuer, the director's death or permanent and total disability, or one day after the date the director ceases to be a director of the issuer
Remarks:
/s/ Allison A. Westfall, Attorney-in-Fact for Joy M. Greenway 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many LDOS shares did the CFO acquire on 06/30/2025?

64.1944 shares were credited through dividend-equivalent rights at $0.00 per share.

What is Christopher Cage鈥檚 total LDOS share ownership after the transaction?

He now holds 29,288.682 indirect shares and 46,953 direct shares.

Was there any sale of LDOS shares reported in this Form 4?

No sales were reported; the filing shows only a small share accrual.

Does the transaction indicate insider sentiment toward LDOS stock?

No. The entry is an automatic, non-cash accrual and is not a discretionary purchase or sale.

What type of plan holds the newly acquired shares?

The shares reside in the Key Executive Stock Deferral Plan, a company deferred-compensation vehicle.
Stock HI logo
Hillenbrand Inc

NYSE:HI

HI Rankings

#2855 Ranked by Market Cap
#815 Ranked by Dividends

HI Latest News

Jul 1, 2025
Hillenbrand Completes Divestiture of Minority Stake in TerraSource Holdings
May 15, 2025
Hillenbrand Announces CFO Transition Plan
May 7, 2025
Hillenbrand Declares Third Quarter Dividend of $0.225 Per Share
Apr 29, 2025
/C O R R E C T I O N -- Hillenbrand/
Apr 29, 2025
Hillenbrand Reports Fiscal Second Quarter 2025 Results

HI Latest SEC Filings

Jul 2, 2025
[Form 4] Hillenbrand, Inc. Insider Trading Activity
Jul 2, 2025
[Form 4] Hillenbrand, Inc. Insider Trading Activity
Jul 2, 2025
[Form 4] Hillenbrand, Inc. Insider Trading Activity
Jul 2, 2025
[Form 4] Hillenbrand, Inc. Insider Trading Activity
Jul 2, 2025
[Form 4] Hillenbrand, Inc. Insider Trading Activity

HI Stock Data

1.45B
69.74M
0.95%
93.65%
3.45%
Specialty Industrial Machinery
Miscellaneous Manufacturing Industries
United States
BATESVILLE